New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...

The ACHIEVE-4 trial evaluated the efficacy and safety of orforglipron in adults with type 2 diabetes and obesity or overweight with increased risk of cardiovascular events.

The findings, which come amid FDA scrutiny of Foundayo’s safety, will enable Lilly to seek a new clearance in diabetes.

Eli Lilly (LLY) stock is in focus as the company plans FDA label expansion for the Foundayo obesity pill after a Phase 3 ...

Once hailed as a global model, Uganda’s refugee policy is now strained by land shortages, ...

That’s a bit of a trick question, because exercise at any time of day is better than no exercise. But a major new review in ...

For those familiar with diabetes technology, the Omnipod platform from Insulet (Nasdaq:PODD) is one most will know about.

If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...

Type 2 diabetes is one of the most common long-term health conditions in the world. It affects millions of people and ...

The physical consequences of stress are also evident, with many children reporting headaches, stomach aches, and sleep ...

NEW YORK (AP) — Two-year-old Bain Brandon has Type 1 diabetes and needs insulin to live. But even with health insurance, the price tag isn’t cheap. A one-month supply of insulin vials and a ...